nicotinamide mononucleotide has been researched along with Anterior Horn Cell Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Chalabi, A; Coleman, MP; Cooper-Knock, J; Danzi, MC; Estiar, MA; Gan-Or, Z; Gilley, J; Goutman, SA; Harms, MB; Houlden, H; Iacoangeli, A; Jackson, O; Kaye, J; Lima, L; Pipis, M; Ravits, J; Reilly, MM; Rouleau, GA; Schüle, R; van Eijk, KR; Xu, J; Züchner, S | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Anterior Horn Cell Disease
| Article | Year |
|---|---|
Enrichment of
Topics: Adult; Aged; Alleles; Amyotrophic Lateral Sclerosis; Animals; Armadillo Domain Proteins; Cytoskeletal Proteins; Female; Humans; Male; Mice; Middle Aged; Motor Neuron Disease; NAD+ Nucleosidase; Nicotinamide Mononucleotide | 2021 |